Bone Marrow TransplantationTransplantation, HomologousBone MarrowGraft vs Host DiseaseBone Marrow CellsWhole-Body IrradiationLeukemiaAnemia, AplasticTransplantation ConditioningTissue DonorsTransplantation ChimeraTransplantation, AutologousBone and BonesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsGraft SurvivalHematopoietic Stem Cell TransplantationHematologic NeoplasmsLeukemia, Myeloid, AcuteLymphocyte DepletionRecurrenceHistocompatibility TestingImmunosuppressive AgentsBusulfanPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibilityLymphocyte TransfusionHematopoietic Stem CellsNuclear FamilyAcute DiseaseTime FactorsRemission InductionBone Marrow PurgingRadiation ChimeraCombined Modality TherapyCyclosporineTransplantation, IsogeneicTreatment OutcomeCyclophosphamideT-LymphocytesGraft vs Host ReactionMice, Inbred C57BLLeukocyte TransfusionImmunosuppressionHematopoiesisBone Marrow DiseasesGraft RejectionSurvival AnalysisRetrospective StudiesCytomegalovirusGraft vs Tumor EffectHepatic Veno-Occlusive DiseaseLeukemia, MyeloidBone Marrow ExaminationBone RemodelingKidney TransplantationMyelodysplastic SyndromesChimeraBone Marrow NeoplasmsLiver TransplantationHLA AntigensHematologic DiseasesGraft vs Leukemia EffectTransplantation ImmunologyLymphoma, Non-HodgkinFatal OutcomeImmunocompromised HostColony-Forming Units AssayMice, Inbred BALB CActuarial AnalysisOpportunistic InfectionsSevere Combined ImmunodeficiencyBone DensitySpleenSurvival RateStem Cell TransplantationLeukocyte CountFollow-Up StudiesCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsFlow CytometryPneumonia, ViralDisease-Free SurvivalBone ResorptionGanciclovirGranulocyte Colony-Stimulating FactorHeart TransplantationAntilymphocyte SerumPancytopeniaInfectionMultiple MyelomaCells, CulturedAntigens, CD34Blood Group IncompatibilityCytarabineMethotrexateLymphomaLeukemia, Myelomonocytic, AcutePolymerase Chain ReactionMycoses